| Market Sector | Growth |
|---|---|
| Vaccine technology | Next-generation vaccines such as nanoparticles (including virus-like particles), mRNA, synthetic, and recombinant vaccines |
| Virtual care | COVID-19; Rise in home-based diagnostics; digital, wearable, connected devices |
| Artificial intelligence (AI)-based medical imaging | Rising volumes of patient imaging, acute shortage of radiologists required to review them |
| Hospital efficiency solutions | Increased aging population and patients with chronic conditions; Shortage of healthcare personnel; push for value-based care |
| Digital biomarkers | Improve personalized treatment, preventive measures; Biopharma precision drug development; Provides reactive, preventive approach to healthcare |
| Microbiome therapeutics | Three potential therapies undergoing pivotal clinical studies and likely to garner U.S. FDA nods in 2021; no approvals yet |
| Combination immuno-oncology (I-O) therapies | Rising cancer cases and increasing R&D investments; Demonstrated effectiveness of combination therapy |
| Laboratory information management solutions (LIMS) | Data migration from legacy infrastructures to the cloud; increasingly complex data management, storage, analytics |
ICONS: ADOBE STOCK
Get curated news on YOUR industry.
Enter your email to receive our newsletters.Loading...
Explore the April 2021 Issue
Check out more from this issue and find your next story to read.
Latest from Today's Medical Developments
- Heule partners with Center for Machining Excellence
- Down the road: What really is next for electric vehicles?
- Driving successful medtech innovation
- Last call for July’s medical manufacturing Lunch + Learn!
- Transform What’s Possible with the Okuma MULTUS U3000
- Okuma: Extraordinary Starts Where Limits End
- Are new medical procedures patentable?
- Caltech's smart capsule to study the health of the GI tract
